Publications found:
73,128
Sort by:
Left Ventricular Dysfunction - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Left Ventricular Dysfunction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Left Ventricular Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
48 pages
Plague - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Plague (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Plague and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
66 pages
Primary Sclerosing Cholangitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Primary Sclerosing Cholangitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Primary Sclerosing Cholangitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
150 pages
Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Venous Leg Ulcers (Crural Ulcer) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Venous Leg Ulcers (Crural Ulcer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
75 pages
Down Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Down Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Down Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
84 pages
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Functional (Non Ulcer) Dyspepsia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
36 pages
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
359 pages
Colitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
116 pages
Tourette Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... . The Tourette Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Tourette syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
74 pages
Ischemia Reperfusion Injury - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ischemia Reperfusion Injury (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ischemia Reperfusion Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
197 pages
Secondary Hyperparathyroidism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Secondary Hyperparathyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Secondary Hyperparathyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
63 pages
Sedation - Pipeline Review, H2 2020
US$ 2,000.00
... . The Sedation (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Sedation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
62 pages
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2020
US$ 2,000.00
... Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
83 pages
Community Acquired Pneumonia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Community Acquired Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
170 pages
Degenerative Disc Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Degenerative Disc Disease (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Degenerative Disc Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
72 pages
Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
97 pages
Botulism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Botulism (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Botulism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
36 pages
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline guide also reviews of key players involved in therapeutic development for Uterine Leiomyoma (Uterine Fibroids) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
117 pages
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ventilator Associated Pneumonia (VAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
187 pages
Streptococcus pyogenes Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
35 pages
Cerebral Palsy - Pipeline Review, H2 2020
US$ 2,000.00
Cerebral Palsy - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H2 2017, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape. Cerebral palsy is a group of disorders that can ...
July 2020
50 pages
Mumps - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Mumps (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Mumps and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
32 pages
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hospital Acquired Pneumonia (HAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
207 pages
Hyperalgesia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Hyperalgesia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Hyperalgesia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
40 pages
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Elephantiasis (Lymphatic Filariasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Elephantiasis (Lymphatic Filariasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
30 pages
Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Microscopic Polyangiitis (MPA) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Microscopic Polyangiitis (MPA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
66 pages
Phenylketonuria (PKU) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Phenylketonuria (PKU) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Phenylketonuria (PKU) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
80 pages
Prader-Willi Syndrome (PWS) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Prader-Willi Syndrome (PWS) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Prader-Willi Syndrome (PWS) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
109 pages
Atypical Hemolytic Uremic Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... Atypical Hemolytic Uremic Syndrome (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under ...
July 2020
128 pages
Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Cluster Headache Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cluster Headache Syndrome (Cluster Headache) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
72 pages
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Primary Biliary Cholangitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Primary Biliary Cholangitis (Primary Biliary Cirrhosis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
149 pages
Intermittent Claudication - Pipeline Review, H2 2020
US$ 2,000.00
Intermittent Claudication - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Intermittent Claudication - Pipeline Review, H2 2020, p...
July 2020
57 pages
Acyl CoA Desaturase - Pipeline Review, H2 2020
US$ 3,500.00
Acyl CoA Desaturase - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Acyl CoA Desaturase - Pipeline Review, H2 2020'; Acyl CoA Desaturase (Fatty Acid Desaturase or Delta...
July 2020
53 pages
Beta Nerve Growth Factor - Pipeline Review, H2 2020
US$ 3,500.00
Beta Nerve Growth Factor - Pipeline Review, H2 2020 SUMMARY Beta Nerve Growth Factor (Beta NGF or NGF) pipeline Target constitutes close to 10 molecules. The latest report Beta Nerve Growth Factor - P...
July 2020
61 pages
Caspase 3 - Pipeline Review, H2 2020
US$ 3,500.00
Caspase 3 - Pipeline Review, H2 2020 SUMMARY Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) pipeline Target constitutes close to 1...
July 2020
80 pages
Hepcidin - Pipeline Review, H2 2020
US$ 3,500.00
Hepcidin - Pipeline Review, H2 2020 SUMMARY Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) pipeline Target constitutes close to 5 molecules. The latest re...
July 2020
41 pages
Histone Deacetylase 8 - Pipeline Review, H2 2020
US$ 3,500.00
Histone Deacetylase 8 - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Histone Deacetylase 8 - Pipeline Review, H2 2020'; Histone Deacetylase 8 (Histone Deacetylase Like...
July 2020
27 pages
Islet Amyloid Polypeptide - Pipeline Review, H2 2020
US$ 3,500.00
Islet Amyloid Polypeptide - Pipeline Review, H2 2020 SUMMARY Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Islet amyloid polypeptide (IAPP)...
July 2020
50 pages
Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020
US$ 3,500.00
Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020 SUMMARY Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Lysosomal alpha-glucosidase is an enzyme encoded...
July 2020
76 pages
Phenylalanine 4 Hydroxylase - Pipeline Review, H2 2020
US$ 3,500.00
Phenylalanine 4 Hydroxylase - Pipeline Review, H2 2020 SUMMARY Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) pipeline Target constitutes close to 8 molecules. The latest rep...
July 2020
56 pages
Protein Kinase C Theta Type - Pipeline Review, H2 2020
US$ 3,500.00
Protein Kinase C Theta Type - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Protein Kinase C Theta Type - Pipeline Review, H2 2020'; Protein Kinase C Theta Type (nPKC Th...
July 2020
33 pages
Serine Protein Kinase ATM - Pipeline Review, H2 2020
US$ 3,500.00
Serine Protein Kinase ATM - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Serine Protein Kinase ATM - Pipeline Review, H2 2020'; Serine Protein Kinase ATM (Ataxia Telang...
July 2020
34 pages
Toll Like Receptor 3 - Pipeline Review, H2 2020
US$ 3,500.00
Toll Like Receptor 3 - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Toll Like Receptor 3 - Pipeline Review, H2 2020'; Toll Like Receptor 3 (CD283 or TLR3) pipeline Targ...
July 2020
87 pages
Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2020
US$ 3,500.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2020 SUMMARY Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - JAK1 is a human tyrosine kinase protein essential for signaling f...
July 2020
273 pages
Histone Deacetylase 4 - Pipeline Review, H2 2020
US$ 3,500.00
Histone Deacetylase 4 - Pipeline Review, H2 2020 SUMMARY Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Histone deacetylase 4 (HDAC4) is a protein encoded by the HDAC4 gene. I...
July 2020
70 pages
